For more information please contact:
Head of Healthcare Investment Banking
Michael Margolis, R.Ph.
Warren Dunnavant II
Head of Equity
Senior Vice President
On February 9th, Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) closed an underwritten public offering of its common stock. Including the partial exercise of the over-allotment option, the Company sold an aggregate of 5,318,700 shares of its common stock. The shares were sold at the public offering price of $5.85 per share, bringing the aggregate gross proceeds from the offering to approximately $31.1 million.
ROTH Capital Partners acted as joint book-running manager for the offering.
About Tonix Pharmaceuticals
Tonix Pharmaceuticals is a clinical-stage company developing first-in-class medicines for common disorders of the central nervous system, including fibromyalgia, post-traumatic stress disorder (PTSD), and episodic tension-type headache (ETTH). These disorders are characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and significant economic burden. Tonix's lead candidate, TNX-102 SL, is intended to be a first-line treatment for fibromyalgia and for PTSD. A Phase 2b trial of TNX-102 SL in fibromyalgia (BESTFIT) has been completed, and Tonix will initiate a Phase 3 program in the second quarter of 2015 to support product registration in the U.S. A Phase 2 trial of TNX-102 SL in PTSD (AtEase) commenced in the first quarter of 2015. A Phase 2 trial of TNX-201 for ETTH will begin in the second quarter of 2015. To learn more, please visit
www.tonixpharma.com. (Source: Company Press Release 2/9/15)
About ROTH Capital Partners
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and maintains offices throughout the U.S. and Hong Kong. For more information on ROTH, please visit